Company Overview of Intersect ENT, Inc.
Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug-eluting implants for patients undergoing sinus surgery to treat chronic sinusitis. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November, 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.
1555 Adams Drive
Menlo Park, CA 94025
Founded in 2003
Key Executives for Intersect ENT, Inc.
Intersect ENT, Inc. Key Developments
Similar Private Companies By Industry
|Oculex Pharmaceuticals, Inc.||United States|
|Ceva Biomune||United States|
|Orphagen Pharmaceuticals, Inc.||United States|
|G2B Pharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Intersect ENT, Inc., please visit www.intersectent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.